Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncology Report

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR.18.1.203PMID 17549369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity.

  2005cited by this paper
• Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.

  2004cited by this paper
• Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil‐based chemotherapy in advanced colorectal cancer patients

  2004cited by this paper
• Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis.

  2004cited by this paper
• Prognostic role of CD8+ tumor infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability

  2004cited by this paper
• Loss of Heterozygosity at the Thymidylate Synthase (TS) Locus on Chromosome 18 Affects Tumor Response and Survival in Individuals Heterozygous for a 28-bp Polymorphism in the TS Gene

  2004cited by this paper
• Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.

  2003cited by this paper
• Activity Gene Abolishes USF-1 Binding and Alters Transcriptional Thymidylate Synthase Tandem Repeat Polymorphism of the ′ A Novel Single Nucleotide Polymorphism within the 5

  2003cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003cited by this paper
• Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.

  2003cited by this paper
• Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer

  2002cited by this paper
• A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil

  2001cited by this paper
• Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

  2001cited by this paper
• Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.

  2001cited by this paper
• Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer

  1996cited by this paper
• Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

  1995cited by this paper
• Adjuvant therapy for colon and rectal cancer. NIH Consensus Development Conference.

  1990cited by this paper
• Structural and functional analysis of the human thymidylate synthase gene.

  1990cited by this paper

• Adjuvant and Neoadjuvant Therapy for Colorectal Cancer

  2019cites this paper
• Polymorphisms in Genes of Drug Targets and Metabolism

  2014cites this paper
• Thymidylate Synthase Gene Polymorphism and Survival of Colorectal Cancer Patients Receiving Adjuvant 5-Fluorouracil

  2013cites this paper
• An integrated analysis of the association between Ts gene polymorphisms and clinical outcome in gastric and colorectal cancer patients treated with 5-FU-based regimens

  2013cites this paper
• Predictive and Prognostic Biomarkers for Colorectal Cancer

  2013cites this paper
• Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis

  2012cites this paper
• Thymidylate Synthase Expression and Prognosis in Colorectal Cancer: A Meta-Analysis of Colorectal Cancer Survival Data

  2012influential citation
• TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients

  2011cites this paper
• The use of proteomics techniques to identify potential markers of early stage colorectal cancer

  2011cites this paper
• TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients

  2010cites this paper
• Relationship between thymidylate synthase (TYMS) gene polymorphism and TYMS protein levels in patients with high-risk breast cancer.

  2010cites this paper
• Pharmacogenetics in Colorectal Cancer

  2010cites this paper
• Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.

  2009cites this paper
• Pharmacogenetics and biomarkers in colorectal cancer

  2009cites this paper
• Approaches to biomarkers in human colorectal cancer: looking back, to go forward.

  2009cites this paper